Sign In
Buy DHR
$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
02:12pm, Wednesday, 10'th Sep 2025
NEW YORK , Sept. 10, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher C
Beckman Coulter Also Announces Development of Aß-42 Research Use Only Immunoassay Test BREA, Calif. , Sept. 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a Danaher company and a leader in gl
Danaher Announces Quarterly Dividend
04:15pm, Tuesday, 09'th Sep 2025
WASHINGTON , Sept. 9, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common s
Danaher Corporation (NYSE: DHR) Investor Alert: Schubert Jonckheer Investigating Possible False Claims, $73 Million in Stock Sales
08:00am, Tuesday, 09'th Sep 2025
SAN FRANCISCO , Sept. 9, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises Danaher Corporation (NYSE: DHR) investors that the firm is investigating potential legal claims relating to alleg
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
09:25pm, Sunday, 07'th Sep 2025
NEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher
NEW YORK , Sept. 5, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Cor
Danaher Gains From Business Strength Amid Persisting Headwinds
12:25pm, Tuesday, 02'nd Sep 2025
DHR posts gains in bioprocessing, biotech and diagnostics, while life sciences softness and high debt weigh.
mRNA Biotechs - Long-Term Value Risks Abound
06:20am, Thursday, 28'th Aug 2025
mRNA vaccine companies are overhyped post-pandemic, facing scientific, operational, and regulatory headwinds that limit long-term investment appeal. Scientific and business risks, including delivery c
Danaher (DHR) Up 6.8% Since Last Earnings Report: Can It Continue?
12:31pm, Thursday, 21'st Aug 2025
Danaher (DHR) reported earnings 30 days ago. What's next for the stock?
Danaher (DHR) Just Overtook the 200-Day Moving Average
10:30am, Monday, 18'th Aug 2025
Danaher (DHR) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, DHR broke through the 200-day moving average, which suggests a long-te
iA Global Buys the Dip in Danaher's Stock Price
10:58am, Wednesday, 13'th Aug 2025
On Aug. 5, iA Global Asset Management Inc. disclosed buying 301,028 shares of Danaher (DHR 1.02%), valued at approximately $58.43 million in Q2 2025.
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of Danaher Corporation
CVS or DHR: Which Is the Better Value Stock Right Now?
12:41pm, Monday, 11'th Aug 2025
Investors with an interest in Medical Services stocks have likely encountered both CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Danaher Stock Closes Near Day's High After Key Trading Signal
07:13am, Monday, 04'th Aug 2025
DHR reverses early down move after Alert
Danaher Appoints Jonathan Leiken as General Counsel
04:15pm, Thursday, 31'st Jul 2025
WASHINGTON , July 31, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Jonathan Leiken has been appointed Senior Vic
